The Debate Before the Claim: Engaging Science on Vaping Without Promising Health Outcomes

Trade bodies are rarely judged on what they decline to say. Yet in contested policy areas, restraint is often the most revealing part of an organisation’s public position. The role of vaping in public health is exactly such an area: a subject where evidence is still being assembled, where regulators are still finding their footing, and where the temptation to convert a contested question into a confident marketing line is considerable. The alternative is to treat the matter as a question still in play, and to say so in plain language.

That distinction sits at the centre of how the Cyprus Vaping Association describes its work. Founded in 2026 under the auspices of the Employers and Industrialists Federation of Cyprus — widely known as OEB — the association states that its main aim is promoting correct information and responsible communication about vaping. The word “communication” carries as much weight as “information”. One describes what is circulated; the other describes how.

What a Stated Goal of Scientific Engagement Actually Says, and What It Leaves Open

Among the six goals the association has published, and which it says it will seek to promote through the collective action of its members in collaboration with OEB, the fourth concerns the research conversation itself. In the association’s own wording, the goal is to utilise the scientific debate around vaping as a potential low-risk alternative option for adult smokers.

Read quickly, a sentence like that can appear to be a conclusion. Read precisely, it is close to the opposite: a description of an organisation’s stance towards a conversation that has not finished. Three words do most of the work. Potential signals the conditional — something still under examination rather than something settled. Adult smokers identifies the group whose circumstances the debate concerns, rather than offering a promise to any individual within it. And scientific debate locates authority outside the association itself, in the research community and the bodies that weigh its output.

The gap between a goal and a finding is not pedantry. A finding can be cited, tested, replicated or contradicted, and it belongs to whoever produced the underlying evidence. A goal belongs to the organisation that sets it, and it can be assessed on whether that organisation behaves consistently with it. When a trade body says it intends to engage a scientific debate, it commits to a posture — attention to evidence, deference to those who generate it, and a willingness to be corrected — rather than to an outcome it cannot deliver.

This is also why the goal is framed as something to be promoted rather than announced as achieved. Stated goals describe direction, not arrival. For the smokers named in the sentence, the practical implication is modest but genuine: what is offered is a debate worth following, not a conclusion worth adopting. That is a deliberately unglamorous position, and for an organisation that does not itself commission or conduct research, it is the only coherent one.

Adult Smokers as the Named Audience, Not the Recipient of a Promise

Naming adult smokers in a public goal is a choice worth examining. It would be simpler, and considerably less exposed, to speak only of “consumers” or “the market”. Naming a group makes a goal more specific, but it also raises the risk that the sentence will be read as a health claim wearing a different coat. Careful drafting can discourage that reading; it cannot prevent it entirely, and no honest association should pretend otherwise.

There is a meaningful difference between describing who a debate is about and predicting what will happen to them. A body that says it wants the scientific debate around vaping considered as a potential option for adult smokers is identifying the population at the centre of the question. It is not stating that any particular smoker will experience a particular result, nor that a product has been demonstrated to do anything in particular. Those would be findings, and findings are not a trade association’s to issue. The full published list, including the exact wording of each goal, can be read directly via the Cyprus Vaping Association website rather than taken second-hand.

The goals that surround this one reinforce the reading. Alongside the commitment to engage the scientific debate, the association lists informing consumers and competent authorities on vaping-related issues, and strengthening dialogue with the state for the adoption of evidence-based and balanced public health policies. Both are verbs that sit upstream of conclusions. A body that informs does not decide; a body that maintains a dialogue does not decree. The pairing is not accidental — it describes the function of an intermediary rather than the authority of an expert body.

A boundary is also drawn around who the communication is not for. The first stated goal is to implement legislation prohibiting the sale of vaping products to minors and to prevent any form of commercial practice that could attract minors. The verb deserves attention: this is something to be promoted, not a law the association has passed. Placing that objective at the head of the list makes the deliberate naming of adult smokers in the fourth goal easier to interpret correctly.

Governance That Has to Match the Wording

Posture is inexpensive; structure is harder. An organisation that says it defers to evidence invites scrutiny of how it is constituted, who speaks for it, and on what authority. Here the published record is recent and modest in scale, and it is better described precisely than inflated.

A founding assembly was held in June 2026, at which seven board members were elected: Antonis Sotiriou, Christos Tamamounas, Stavros Charalambous, Christos Savva, Steve Towler, Kostas Nikolaou and Nikolas Papasolomontos. Officer positions followed at a meeting in September 2026 at the OEB Building in Nicosia, producing the current roster: Kostas Nikolaou as President, Christos Tamamounas as Vice President, Stavros Charalambous as Secretary, Steve Towler as Treasurer, Nikolas Papasolomontos as Director of International Affairs, with Antonis Sotiriou and Christos Savva serving as board members.

In August 2026, OEB announced the association’s inclusion in the ranks of its Member Associations, describing it as further strengthening the representation of businesses operating in emerging and regulated sectors of the economy. The same announcement characterised the association as representing companies active in manufacturing, wholesale and retail trade and in the export of vaping products, contributing to what it called a dynamic and extrovert sector of the Cypriot economy. OEB’s welcome expressed confidence that the cooperation would promote responsible entrepreneurship and an operating framework combining the protection of public health with business activity — wording attributable to OEB, not to the association itself.

Representing commercial interests while holding back from health assertions is not a contradiction, but it is a tension that has to be managed openly. Two further goals point to how: the promotion of responsible business activity in the vaping products market, and the consolidation of members’ professional ethics in full compliance with the national and European regulatory framework. Together with the commitment to evidence-based policy dialogue, they suggest that credibility is treated as an operational requirement rather than a slogan. For readers following the vaping question, that is the useful test — not whether an association repeats the loudest claim available, but whether its published aims survive being read closely, word by word.